Inovio Pharmaceuticals
INO
#9349
Rank
C$0.14 B
Marketcap
C$1.79
Share price
-4.41%
Change (1 day)
-34.31%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -C$0.16 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are C$0.18 Million. In 2024 the company made an earning of -C$0.15 Billion, an increase over its 2023 earnings that were of -C$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.16 Billion2.91%
2024 -C$0.15 Billion-20.03%
2023 -C$0.19 Billion-51.56%
2022 -C$0.39 Billion-8.26%
2021 -C$0.42 Billion95.4%
2020 -C$0.22 Billion36.62%
2019 -C$0.16 Billion20.19%
2018 -C$0.13 Billion10.94%
2017 -C$0.12 Billion9.59%
2016 -C$0.11 Billion118.9%
2015 -C$48.52 Million-10.67%
2014 -C$54.31 Million83.32%
2013 -C$29.63 Million
2011 -C$30.56 Million15.64%
2010 -C$26.43 Million37.7%
2009 -C$19.2 Million2.19%
2008 -C$18.78 Million-14.09%
2007 -C$21.86 Million19.12%
2006 -C$18.35 Million9.62%
2005 -C$16.74 Million5.77%
2004 -C$15.83 Million73.08%
2003 -C$9.15 Million12.75%
2002 -C$8.12 Million
2000 -C$12.28 Million53.93%
1999 -C$7.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.71 B-24,134.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.70 B-14,702.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.56 B-9,898.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.46 B-9,163.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.08 B-12,267.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.76 B-9,361.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-C$3.79 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$0.47 B-419.30%๐Ÿ‡บ๐Ÿ‡ธ USA